Clinical microbiologist are facing challenge to defeat the bacterial infections like Methicillin ResistantStaphylococcus aureus (MRSA) in humans; due to unique resistance in bacterial strain. There are limited medication options left to conquer this deadly toxicities, if holistic approach is ignored. Also the linked complications and consequences of infections may increase beyond threshold levels; if exercise only a single array of drug therapy. This empirical study aims to create synergy by adopting an integrated drug therapy approach for optimum treatment. This research article is based on primary microbial data collection (from sputum, urine and blood) in hospital; where the experiment focuses to investigate the highest risk vulnerable area. The result depicts high prevalence of MRSA in blood sample (50 %) among in-door patients of age above 50. The preventive and curative measures are discussed along with alternative multiple array of medication with prudent selection to achieve targeted and optimum outcome.

Exploring optimal cure of Methicillin Resistant Staphylococcus aureus (MRSA), has been consistently challenged by clinical physicians and microbiologist. The fatal bacterial infection, Methicillin Resistant Staphylococcus aureus (MRSA), shows unique resistance; when selected drugs are tested on human patients. If holistic approach is overlooked, less possibilities are left for medication to curtail this lethal toxicity. If single range of drug treatment is exercised only, the associated complications and consequences of infections may proliferate beyond threshold levels. The research article is an outcome from primary microbial data collection (from urine and blood) in hospital. The focus of experiment is to scrutinize the highest risk vulnerable hospital area including sampled fluid. The preventive and therapeutic measures are discussed along with multiple substitutes of medication with prudent selection to achieve targeted and optimum outcome.